Acarbose and Secondary Prevention After Coronary Stenting
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the intervention for newly diagnosed
abnormal glucose tolerance after coronary stenting will improve the long-term clinical
outcome.
Phase:
Phase 3
Details
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan Translational Research Informatics Center, Kobe, Hyogo, Japan
Collaborators:
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan Kobe City General Hospital